51
|
Delabar JM, Allinquant B, Bianchi D, Blumenthal T, Dekker A, Edgin J, O'Bryan J, Dierssen M, Potier MC, Wiseman F, Guedj F, Créau N, Reeves R, Gardiner K, Busciglio J. Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society. Mol Syndromol 2016; 7:251-261. [PMID: 27867340 DOI: 10.1159/000449049] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/21/2016] [Indexed: 01/26/2023] Open
Abstract
Down syndrome (DS) is the most common genetic cause of intellectual disability (ID) in humans with an incidence of ∼1:1,000 live births worldwide. It is caused by the presence of an extra copy of all or a segment of the long arm of human chromosome 21 (trisomy 21). People with DS present with a constellation of phenotypic alterations involving most organs and organ systems. ID is present in all people with DS, albeit with variable severity. DS is also the most frequent genetic cause of Alzheimer's disease (AD), and ∼50% of those with DS will develop AD-related dementia. In the last few years, significant progress has been made in understanding the crucial genotype-phenotype relationships in DS, in identifying the alterations in molecular pathways leading to the various clinical conditions present in DS, and in preclinical evaluations of potential therapies to improve the overall health and well-being of individuals with DS. In June 2015, 230 scientists, advocates, patients, and family members met in Paris for the 1st International Conference of the Trisomy 21 Research Society. Here, we report some of the most relevant presentations that took place during the meeting.
Collapse
Affiliation(s)
- Jean-Maurice Delabar
- Brain and Spine Institute, Hospital Pitié-Salpêtrière, Paris, France; University of Paris Diderot, Paris, France
| | | | | | - Tom Blumenthal
- Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colo., USA
| | - Alain Dekker
- Department of Neurology, University Medical Center, Groningen, The Netherlands
| | - Jamie Edgin
- Department of Psychology, University of Arizona, Tucson, Ariz., USA
| | - John O'Bryan
- Department of Pharmacology, University of Illinois at Chicago, Chicago, Ill., USA
| | - Mara Dierssen
- Center for Genomic Regulation (CRG), Barcelona, Spain
| | | | | | | | - Nicole Créau
- Brain and Spine Institute, Hospital Pitié-Salpêtrière, Paris, France; University of Paris Diderot, Paris, France
| | - Roger Reeves
- John Hopkins University School of Medicine, Baltimore, Md., USA
| | | | - Jorge Busciglio
- Department of Neurobiology and Behavior, University of California-Irvine, Irvine, Calif., USA
| |
Collapse
|
52
|
de la Torre R, de Sola S, Hernandez G, Farré M, Pujol J, Rodriguez J, Espadaler JM, Langohr K, Cuenca-Royo A, Principe A, Xicota L, Janel N, Catuara-Solarz S, Sanchez-Benavides G, Bléhaut H, Dueñas-Espín I, del Hoyo L, Benejam B, Blanco-Hinojo L, Videla S, Fitó M, Delabar JM, Dierssen M. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol 2016; 15:801-810. [DOI: 10.1016/s1474-4422(16)30034-5] [Citation(s) in RCA: 178] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2015] [Revised: 03/23/2016] [Accepted: 03/31/2016] [Indexed: 12/29/2022]
|
53
|
Pujol J, Fenoll R, Macià D, Martínez-Vilavella G, Alvarez-Pedrerol M, Rivas I, Forns J, Deus J, Blanco-Hinojo L, Querol X, Sunyer J. Airborne copper exposure in school environments associated with poorer motor performance and altered basal ganglia. Brain Behav 2016; 6:e00467. [PMID: 27134768 PMCID: PMC4842931 DOI: 10.1002/brb3.467] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2015] [Revised: 03/02/2016] [Accepted: 03/09/2016] [Indexed: 11/25/2022] Open
Abstract
INTRODUCTION Children are more vulnerable to the effects of environmental elements. A variety of air pollutants are among the identified factors causing neural damage at toxic concentrations. It is not obvious, however, to what extent the tolerated high levels of air pollutants are able to alter brain development. We have specifically investigated the neurotoxic effects of airborne copper exposure in school environments. METHODS Speed and consistency of motor response were assessed in 2836 children aged from 8 to 12 years. Anatomical MRI, diffusion tensor imaging, and functional MRI were used to directly test the brain repercussions in a subgroup of 263 children. RESULTS Higher copper exposure was associated with poorer motor performance and altered structure of the basal ganglia. Specifically, the architecture of the caudate nucleus region was less complete in terms of both tissue composition and neural track water diffusion. Functional MRI consistently showed a reciprocal connectivity reduction between the caudate nucleus and the frontal cortex. CONCLUSIONS The results establish an association between environmental copper exposure in children and alterations of basal ganglia structure and function.
Collapse
Affiliation(s)
- Jesus Pujol
- MRI Research Unit Hospital del Mar Barcelona Spain; Centro Investigación Biomédica en Red de Salud Mental, CIBERSAM G21 Barcelona Spain
| | | | - Dídac Macià
- MRI Research Unit Hospital del Mar Barcelona Spain
| | | | - Mar Alvarez-Pedrerol
- Centre for Research in Environmental Epidemiology (CREAL) Barcelona Catalonia Spain; Pompeu Fabra University Barcelona Catalonia Spain; Ciber on Epidemiology and Public Health (CIBERESP) Barcelona Spain
| | - Ioar Rivas
- Centre for Research in Environmental Epidemiology (CREAL) Barcelona Catalonia Spain; Pompeu Fabra University Barcelona Catalonia Spain; Ciber on Epidemiology and Public Health (CIBERESP) Barcelona Spain; Institute of Environmental Assessment and Water Research (IDAEA-CSIC) Barcelona Catalonia Spain
| | - Joan Forns
- Centre for Research in Environmental Epidemiology (CREAL) Barcelona Catalonia Spain; Pompeu Fabra University Barcelona Catalonia Spain; Ciber on Epidemiology and Public Health (CIBERESP) Barcelona Spain
| | - Joan Deus
- MRI Research Unit Hospital del Mar Barcelona Spain; Department of Clinical and Health Psychology Autonomous University of Barcelona Barcelona Spain
| | | | - Xavier Querol
- Institute of Environmental Assessment and Water Research (IDAEA-CSIC) Barcelona Catalonia Spain
| | - Jordi Sunyer
- Centre for Research in Environmental Epidemiology (CREAL) Barcelona Catalonia Spain; Pompeu Fabra University Barcelona Catalonia Spain; Ciber on Epidemiology and Public Health (CIBERESP) Barcelona Spain; IMIM (Hospital del Mar Medical Research Institute) Barcelona Catalonia Spain
| |
Collapse
|
54
|
Roshan Lal TR, Kliewer MA, Lopes T, Rebsamen SL, O'Connor J, Grados MA, Kimball A, Clemens J, Kline AD. Cornelia de Lange syndrome: Correlation of brain MRI findings with behavioral assessment. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS 2016; 172:190-7. [PMID: 27164360 DOI: 10.1002/ajmg.c.31503] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Neurobehavioral and developmental issues with a broad range of deficits are prominent features of Cornelia de Lange syndrome (CdLS), a disorder due to disruption of the cohesin protein complex. The etiologic relationship of these clinical findings to anatomic abnormalities on neuro-imaging studies has not, however, been established. Anatomic abnormalities in the brain and central nervous system specific to CdLS have been observed, including changes in the white matter, brainstem, and cerebellum. We hypothesize that location and severity of brain abnormalities correlate with clinical phenotype in CdLS, as seen in other developmental disorders. In this study, we retrospectively evaluated brain MRI studies of 15 individuals with CdLS and compared these findings to behavior at the time of the scan. Behavior was assessed using the Aberrant Behavior Checklist (ABC), a validated behavioral assessment tool with several clinical features. Ten of fifteen (67%) of CdLS patients had abnormal findings on brain MRI, including cerebral atrophy, white matter changes, cerebellar hypoplasia, and enlarged ventricles. Other findings included pituitary tumors or cysts, Chiari I malformation and gliosis. Abnormal behavioral scores in more than one behavioral area were seen in all but one patient. All 5 of the 15 (33%) patients with normal structural MRI studies had abnormal ABC scores. All normal ABC scores were noted in only one patient and this was correlated with moderately abnormal MRI changes. Although our cohort is small, our results suggest that abnormal behaviors can exist in individuals with CdLS in the setting of relatively normal structural brain findings. © 2016 Wiley Periodicals, Inc.
Collapse
|
55
|
Ruiz-Mejias M, Martinez de Lagran M, Mattia M, Castano-Prat P, Perez-Mendez L, Ciria-Suarez L, Gener T, Sancristobal B, García-Ojalvo J, Gruart A, Delgado-García JM, Sanchez-Vives MV, Dierssen M. Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex. J Neurosci 2016; 36:3648-59. [PMID: 27030752 PMCID: PMC6601739 DOI: 10.1523/jneurosci.2517-15.2016] [Citation(s) in RCA: 43] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2015] [Revised: 01/12/2016] [Accepted: 01/14/2016] [Indexed: 11/21/2022] Open
Abstract
The dual-specificity tyrosine phosphorylation-regulated kinase DYRK1A is a serine/threonine kinase involved in neuronal differentiation and synaptic plasticity and a major candidate of Down syndrome brain alterations and cognitive deficits. DYRK1A is strongly expressed in the cerebral cortex, and its overexpression leads to defective cortical pyramidal cell morphology, synaptic plasticity deficits, and altered excitation/inhibition balance. These previous observations, however, do not allow predicting how the behavior of the prefrontal cortex (PFC) network and the resulting properties of its emergent activity are affected. Here, we integrate functional, anatomical, and computational data describing the prefrontal network alterations in transgenic mice overexpressingDyrk1A(TgDyrk1A). Usingin vivoextracellular recordings, we show decreased firing rate and gamma frequency power in the prefrontal network of anesthetized and awakeTgDyrk1Amice. Immunohistochemical analysis identified a selective reduction of vesicular GABA transporter punctae on parvalbumin positive neurons, without changes in the number of cortical GABAergic neurons in the PFC ofTgDyrk1Amice, which suggests that selective disinhibition of parvalbumin interneurons would result in an overinhibited functional network. Using a conductance-based computational model, we quantitatively demonstrate that this alteration could explain the observed functional deficits including decreased gamma power and firing rate. Our results suggest that dysfunction of cortical fast-spiking interneurons might be central to the pathophysiology of Down syndrome. SIGNIFICANCE STATEMENT DYRK1Ais a major candidate gene in Down syndrome. Its overexpression results into altered cognitive abilities, explained by defective cortical microarchitecture and excitation/inhibition imbalance. An open question is how these deficits impact the functionality of the prefrontal cortex network. Combining functional, anatomical, and computational approaches, we identified decreased neuronal firing rate and deficits in gamma frequency in the prefrontal cortices of transgenic mice overexpressingDyrk1A We also identified a reduction of vesicular GABA transporter punctae specifically on parvalbumin positive interneurons. Using a conductance-based computational model, we demonstrate that this decreased inhibition on interneurons recapitulates the observed functional deficits, including decreased gamma power and firing rate. Our results suggest that dysfunction of cortical fast-spiking interneurons might be central to the pathophysiology of Down syndrome.
Collapse
Affiliation(s)
- Marcel Ruiz-Mejias
- Systems Neuroscience, August Pi i Sunyer Biomedical research Institute (IDIBAPS), 08036 Barcelona, Spain
| | - Maria Martinez de Lagran
- Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, 08003 Barcelona, Spain, Pompeu Fabra University (UPF), 08003 Barcelona, Spain, Centre for Biomedical Research on Rare Diseases (CIBERER) 08003 Barcelona, Spain
| | | | - Patricia Castano-Prat
- Systems Neuroscience, August Pi i Sunyer Biomedical research Institute (IDIBAPS), 08036 Barcelona, Spain
| | - Lorena Perez-Mendez
- Systems Neuroscience, August Pi i Sunyer Biomedical research Institute (IDIBAPS), 08036 Barcelona, Spain
| | - Laura Ciria-Suarez
- Systems Neuroscience, August Pi i Sunyer Biomedical research Institute (IDIBAPS), 08036 Barcelona, Spain
| | - Thomas Gener
- Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, 08003 Barcelona, Spain, Pompeu Fabra University (UPF), 08003 Barcelona, Spain, Centre for Biomedical Research on Rare Diseases (CIBERER) 08003 Barcelona, Spain
| | - Belen Sancristobal
- Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, 08003 Barcelona, Spain, Pompeu Fabra University (UPF), 08003 Barcelona, Spain, Centre for Biomedical Research on Rare Diseases (CIBERER) 08003 Barcelona, Spain
| | | | - Agnès Gruart
- Neuroscience Department, Pablo de Olavide University 41013 Seville, Spain, and
| | | | - Maria V Sanchez-Vives
- Systems Neuroscience, August Pi i Sunyer Biomedical research Institute (IDIBAPS), 08036 Barcelona, Spain, Catalan Institution for Research and Advanced Studies (ICREA) 08010 Barcelona, Spain
| | - Mara Dierssen
- Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, 08003 Barcelona, Spain, Pompeu Fabra University (UPF), 08003 Barcelona, Spain, Centre for Biomedical Research on Rare Diseases (CIBERER) 08003 Barcelona, Spain,
| |
Collapse
|
56
|
Karmiloff-Smith A, Al-Janabi T, D'Souza H, Groet J, Massand E, Mok K, Startin C, Fisher E, Hardy J, Nizetic D, Tybulewicz V, Strydom A. The importance of understanding individual differences in Down syndrome. F1000Res 2016; 5:F1000 Faculty Rev-389. [PMID: 27019699 PMCID: PMC4806704 DOI: 10.12688/f1000research.7506.1] [Citation(s) in RCA: 113] [Impact Index Per Article: 14.1] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 03/17/2016] [Indexed: 12/24/2022] Open
Abstract
In this article, we first present a summary of the general assumptions about Down syndrome (DS) still to be found in the literature. We go on to show how new research has modified these assumptions, pointing to a wide range of individual differences at every level of description. We argue that, in the context of significant increases in DS life expectancy, a focus on individual differences in trisomy 21 at all levels-genetic, cellular, neural, cognitive, behavioral, and environmental-constitutes one of the best approaches for understanding genotype/phenotype relations in DS and for exploring risk and protective factors for Alzheimer's disease in this high-risk population.
Collapse
Affiliation(s)
- Annette Karmiloff-Smith
- Centre for Brain & Cognitive Development, Birkbeck University of London, London, WC1E 7HX, UK
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
| | - Tamara Al-Janabi
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- Division of Psychiatry, University College London, London, W1T 7NF, UK
| | - Hana D'Souza
- Centre for Brain & Cognitive Development, Birkbeck University of London, London, WC1E 7HX, UK
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
| | - Jurgen Groet
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- The Blizard Institute, Barts & The London School of Medicine, Queen Mary University of London, London, E1 2AT, UK
| | - Esha Massand
- Centre for Brain & Cognitive Development, Birkbeck University of London, London, WC1E 7HX, UK
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
| | - Kin Mok
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- Department of Molecular Neuroscience, University College London Institute of Neurology, London, WC1N 3BG, UK
- Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, China
| | - Carla Startin
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- Division of Psychiatry, University College London, London, W1T 7NF, UK
| | - Elizabeth Fisher
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- Department of Neurodegenerative Disease, Institute of Neurology, London, WC1N 3BG, UK
| | - John Hardy
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- Department of Molecular Neuroscience, University College London Institute of Neurology, London, WC1N 3BG, UK
| | - Dean Nizetic
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- The Blizard Institute, Barts & The London School of Medicine, Queen Mary University of London, London, E1 2AT, UK
- Lee Kong Chian School of Medicine, Nanyang Technological University, Biopolis, 138673, Singapore
| | - Victor Tybulewicz
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- Francis Crick Institute, London, NW7 1AA, UK
- Department of Medicine, Imperial College London, London, W12 0NN, UK
| | - Andre Strydom
- The London Down Syndrome Consortium (LonDownS), University College London, London, UK
- Division of Psychiatry, University College London, London, W1T 7NF, UK
| |
Collapse
|
57
|
Edgin JO, Clark CAC, Massand E, Karmiloff-Smith A. Building an adaptive brain across development: targets for neurorehabilitation must begin in infancy. Front Behav Neurosci 2015; 9:232. [PMID: 26441566 PMCID: PMC4565977 DOI: 10.3389/fnbeh.2015.00232] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2015] [Accepted: 08/17/2015] [Indexed: 11/13/2022] Open
Abstract
Much progress has been made toward behavioral and pharmacological intervention in intellectual disability, which was once thought too difficult to treat. Down syndrome (DS) research has shown rapid advances, and clinical trials are currently underway, with more on the horizon. Here, we review the literature on the emergent profile of cognitive development in DS, emphasizing that treatment approaches must consider how some "end state" impairments, such as language deficits, may develop from early alterations in neural systems beginning in infancy. Specifically, we highlight evidence suggesting that there are pre- and early postnatal alterations in brain structure and function in DS, resulting in disturbed network function across development. We stress that these early alterations are likely amplified by Alzheimer's disease (AD) progression and poor sleep. Focusing on three network hubs (prefrontal cortex, hippocampus, and cerebellum), we discuss how these regions may relate to evolving deficits in cognitive function in individuals with DS, and to their language profile in particular.
Collapse
Affiliation(s)
- Jamie O. Edgin
- Department of Psychology, University of ArizonaTucson, AZ, USA
- Sonoran University Center for Excellence in Developmental DisabilitiesTucson, AZ, USA
| | | | - Esha Massand
- Centre for Brain and Cognitive Development, Birkbeck, University of LondonLondon, UK
| | | |
Collapse
|
58
|
McGuire BE, Defrin R. Pain perception in people with Down syndrome: a synthesis of clinical and experimental research. Front Behav Neurosci 2015; 9:194. [PMID: 26283936 PMCID: PMC4519755 DOI: 10.3389/fnbeh.2015.00194] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2015] [Accepted: 07/10/2015] [Indexed: 12/18/2022] Open
Abstract
People with an intellectual disability experience both acute and chronic pain with at least the same frequency as the general population. However, considerably less is known about the pain perception of people with Down syndrome. In this review paper, we evaluated the available clinical and experimental evidence. Some experimental studies of acute pain have indicated that pain threshold was higher than normal but only when using a reaction time method to measure pain sensitivity. However, when reaction time is not part of the calculation of the pain threshold, pain sensitivity in people with Down syndrome is in fact lower than normal (more sensitive to pain). Clinical studies of chronic pain have shown that people with an intellectual disability experience chronic pain and within that population, people with Down syndrome also experience chronic pain, but the precise prevalence of chronic pain in Down syndrome has yet to be established. Taken together, the literature suggests that people with Down syndrome experience pain, both acute and chronic, with at least the same frequency as the rest of the population. Furthermore, the evidence suggests that although acute pain expression appears to be delayed, once pain is registered, there appears to be a magnified pain response. We conclude by proposing an agenda for future research in this area.
Collapse
Affiliation(s)
- Brian E McGuire
- School of Psychology and Centre for Pain Research, National University of Ireland Galway, Ireland
| | - Ruth Defrin
- Department of Physical Therapy at the Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel-Aviv University Tel-Aviv, Israel
| |
Collapse
|
59
|
Anderson JS, Treiman SM, Ferguson MA, Nielsen JA, Edgin JO, Dai L, Gerig G, Korenberg JR. Violence: heightened brain attentional network response is selectively muted in Down syndrome. J Neurodev Disord 2015; 7:15. [PMID: 26131023 PMCID: PMC4486123 DOI: 10.1186/s11689-015-9112-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Accepted: 05/26/2015] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND The ability to recognize and respond appropriately to threat is critical to survival, and the neural substrates subserving attention to threat may be probed using depictions of media violence. Whether neural responses to potential threat differ in Down syndrome is not known. METHODS We performed functional MRI scans of 15 adolescent and adult Down syndrome and 14 typically developing individuals, group matched by age and gender, during 50 min of passive cartoon viewing. Brain activation to auditory and visual features, violence, and presence of the protagonist and antagonist were compared across cartoon segments. fMRI signal from the brain's dorsal attention network was compared to thematic and violent events within the cartoons between Down syndrome and control samples. RESULTS We found that in typical development, the brain's dorsal attention network was most active during violent scenes in the cartoons and that this was significantly and specifically reduced in Down syndrome. When the antagonist was on screen, there was significantly less activation in the left medial temporal lobe of individuals with Down syndrome. As scenes represented greater relative threat, the disparity between attentional brain activation in Down syndrome and control individuals increased. There was a reduction in the temporal autocorrelation of the dorsal attention network, consistent with a shortened attention span in Down syndrome. Individuals with Down syndrome exhibited significantly reduced activation in primary sensory cortices, and such perceptual impairments may constrain their ability to respond to more complex social cues such as violence. CONCLUSIONS These findings may indicate a relative deficit in emotive perception of violence in Down syndrome, possibly mediated by impaired sensory perception and hypoactivation of medial temporal structures in response to threats, with relative preservation of activity in pro-social brain regions. These findings indicate that specific genetic differences associated with Down syndrome can modulate the brain's response to violence and other complex emotive ideas.
Collapse
Affiliation(s)
- Jeffrey S Anderson
- Department of Radiology, 1A71 School of Medicine, University of Utah, Salt Lake City, UT 84132 USA ; Interdepartmental Program in Neuroscience, University of Utah, Salt Lake City, USA ; The Brain Institute at the University of Utah, Salt Lake City, USA ; Department of Bioengineering, University of Utah, Salt Lake City, USA
| | - Scott M Treiman
- The Brain Institute at the University of Utah, Salt Lake City, USA
| | | | - Jared A Nielsen
- Interdepartmental Program in Neuroscience, University of Utah, Salt Lake City, USA
| | - Jamie O Edgin
- Department of Psychology, University of Arizona, Tucson, USA
| | - Li Dai
- Department of Pediatrics, University of Utah, Salt Lake City, USA
| | - Guido Gerig
- The Brain Institute at the University of Utah, Salt Lake City, USA ; Department of Bioengineering, University of Utah, Salt Lake City, USA ; Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, USA
| | - Julie R Korenberg
- Interdepartmental Program in Neuroscience, University of Utah, Salt Lake City, USA ; The Brain Institute at the University of Utah, Salt Lake City, USA ; Department of Pediatrics, University of Utah, Salt Lake City, USA
| |
Collapse
|